Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to determine if a change in patient reported pain, nausea and
vomiting after total knee and hip arthroplasty could be observed with the substitution of
Intravenous meloxicam for ketorolac in the current established peri-operative pain protocol
and if these changes lead to a decrease in opioid consumption (in morphine equivalents).